Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.255 EUR | -5.03% | -6.93% | -34.62% |
04-04 | Celyad Oncology SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
02-09 | Celyad Oncology Seeks Termination of Reporting Obligations to US SEC | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-34.62% | 12.14M | |
+25.26% | 46.56B | |
+45.49% | 41.67B | |
-0.40% | 41.16B | |
+34.06% | 32.4B | |
+20.80% | 28.18B | |
-6.35% | 28.1B | |
+49.29% | 14.52B | |
+47.88% | 13.74B | |
+1.86% | 12.17B |
- Stock Market
- Equities
- CYAD Stock
- News Celyad Oncology SA
- Celyad Announces Registration of the First Patient in the Belgian THINK Trial